Hot topics in geriatrics

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 58, Issue 1, 2003, Pages 30-36

  Morley, John E ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; BISPHOSPHONIC ACID DERIVATIVE; CYTOKINE; FATTY ACID; HOMOCYSTEINE; INFLUENZA VACCINE; INTERLEUKIN 6; PNEUMOCOCCUS VACCINE; RISEDRONIC ACID; TESTOSTERONE; VITAMIN D; ZOLEDRONIC ACID;

AGING; ALZHEIMER DISEASE; ANOREXIA; ANTHRAX; ATHEROSCLEROTIC PLAQUE; BEHAVIOR DISORDER; BIOLOGICAL WARFARE; BLOOD BRAIN BARRIER; BONE DENSITY; BONE MINERAL; CALORIC RESTRICTION; CANCER SCREENING; CARDIOVASCULAR DISEASE; CAREGIVER; COGNITION; COGNITIVE DEFECT; COMORBIDITY; DECUBITUS; DEMENTIA; DEPRESSION; DISABILITY; DISEASE MARKER; EDITORIAL; GENETIC ANALYSIS; GENETIC MANIPULATION; GERIATRICS; HEALTH CARE COST; HERBAL MEDICINE; HIP FRACTURE; INFECTION; INFLUENZA VACCINATION; INSTITUTIONAL CARE; LIFE EXPECTANCY; LIPID DIET; MORTALITY; MUSCLE ATROPHY; NEUROFIBRILLARY TANGLE; NURSING HOME; NUTRITION; NUTRITIONAL DEFICIENCY; OSTEOPOROSIS; OUTCOMES RESEARCH; PAIN; PHYSICAL ACTIVITY; POLYPHARMACY; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; QUALITY OF LIFE; SCABIES; SENILE PLAQUE; TASK PERFORMANCE; VACCINATION; WEST NILE FLAVIVIRUS;

AGED; AGED, 80 AND OVER; AGING; FEMALE; GERIATRIC NURSING; GERIATRICS; HEALTH POLICY; HUMANS; MALE; NEEDS ASSESSMENT; PHYSICIAN'S PRACTICE PATTERNS; POLICY MAKING; QUALITY OF HEALTH CARE; RISK ASSESSMENT; UNITED STATES;

ANTHRAX; FLAVIVIRUS; WEST NILE VIRUS;

EID: 0037240348     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (207)

1. Olshansky SJ, Hayflick L, Carnes BA. Position statement on human aging. J Gerontol Biol Sci. 2002;57A:B292-B297.
2. Fisher A, Morley JE. Anti-aging medicine: the good, the bad, and the ugly. J Gerontol Med Sci. 2002;57A:M636-M639.
3. Butler RN, Fossel M, Harman SM, et al. Is there an anti-aging medicine? J Gerontol Biol Sci. 2002;57A:B333-B338.
4. Cypser JR, Johnson TE. Multiple stressors in Caenorhabditis elegans induce stress hormesis and extended longevity. J Gerontol Biol Sci. 2002;57A:B109-B114.
5. Johnson TE, Wu DQ, Tedesco P, Dames S, Vaupel JW. Age-specific demographic profiles of longevity mutants in Caenorhabditis elegans show segmental effects. J Gerontol Biol Sci. 2001;56A:B331-B339.
6. Frisoni GB, Louhija J, Geroldi C, Trabucchi M. Longevity and the epsilon 2 allele of apolipoprotein E: the Finnish Centenarians Study. J Gerontol Med Sci. 2001;56A:M75-M78.
7. Rimon E, Levy S, Sapir A, et al. Diagnosis of iron deficiency anemia in the elderly by transferring receptor-ferritin index. Arch Intern Med. 2002;162:445-449.
8. Perls T. Genetic and phenotypic markers among centenarians. J Gerontol Med Sci. 2001;56A:M67-M70.
9. Barzilai N, Shuldiner AR. Searching for human longevity genes: the future history of gerontology in the postgenomic era. J Gerontol Med Sci. 2001;56A:M83-M87.
10. McNeal MC, Zareparsi S, Camicioli R, et al. Predictors of healthy brain aging. J Gerontol Biol Sci. 2001;56A:B294-B301.
11. Blazer DG, Fillenbaum G, Burchett B. The APOE-E4 allele and the risk of functional decline in a community sample of African American and white older adults. J Gerontol Med Sci. 2001;56A:M785-M789.
12. Bartke A, Coshigano K, Kopchick J, et al. Genes that prolong life: relationships of growth hormone and growth to aging and life span. J Gerontol Biol Sci. 2001;56A:B340-B349.
13. Atzmon G, Gabriely I, Greiner W, Davidson D, Schechter C, Barzilai N. Plasma HDL levels highly correlate with cognitive function in exceptional longevity. J Gerontol Med Sci. 2002;57A:M712-M715.
14. Zuliani G, Cherubini A, Volpato S, et al. Genetic factors associated with the absence of atherosclerosis in octogenarians. J Gerontol Med Sci. 2002;57A:M611-M615.
15. Blumenthal HT. Milestone or genomania? The relevance of the human genome project to biological aging and the age-related diseases. J Gerontol Med Sci. 2001;56A:M529-M537.
16. Meyer JU. Retina implant - a bioMEMS challenge. Sensors Act A Phys. 2002;97(8):1-9.
17. Mobbs CV, Bray GA, Atkinson RL, et al. Neuroendocrine and pharmacological manipulations to assess how caloric restriction increases life span. J Gerontol Biol Sci. 2001;56A(special issue):34-44.
18. Poehlman ET, Turturro A, Bodkin N, et al. Caloric restriction mimetics: physical activity and body composition changes. J Gerontol Biol Sci. 2001;56A(special issue):45-54.
19. Kirk KL. Dietary restriction and aging: comparative tests of evolutionary hypotheses. J Gerontol Biol Sci. 2001;56A:B123-B129.
20. Allison DB, Miller RA, Austad SN, et al. Genetic variability in responses to caloric restriction in animals and in regulation of metabolism and obesity in humans. J Gerontol Med Sci. 2001;56A(special issue):55-65.
21. Walford RL, Mock D, Verdery R, MacCallum T. Calorie restriction in Biosphere 2: alterations in physiologic, hematolic, hormonal, and biochemical parameters in humans restricted for a 2-year period. J Gerontol Biol Sci. 2002;57A:B211-B224.
22. Hadley EC, Dutta C, Finkelstein J, et al. Human implications of caloric restriction's effects on aging in laboratory animals: an overview of opportunities for research. J Gerontol Biol Sci. 2001;56A (special issue):5-6.
23. Weindruch R, Keenan KP, Carney JM, et al. Caloric restriction mimetics: metabolic interventions. J Gerontol Biol Sci. 2001;56A(special issue):20-33.
24. Morley JE. Nutrition in the elderly. Curr Opin Gastroent. 2002;18:240-245.
25. Roberts SB, Pi-Sunyer X, Kuller L, et al. Physiologic effects of lowering caloric intake in nonhuman primates and nonobese humans. J Gerontol Med Sci. 2001;56(special issue):66-75.
26. Morley JE. Decreased food intake with aging. J Gerontol Med Sci. 2001;56(special issue 2):81-88.
27. Amarantos E, Martinez S, Dwyer J. Nutrition and quality of life in older adults. J Gerontol Med Sci. 2001;56(special issue 2):54-64.
28. Thomas DR, Zdrowski CD, Wilson MM, et al. Malnutrition in subacute care. Am J Clin Nutr. 2002;75:308-313.
29. Liu L, Bopp MM, Roberson PK, Sullivan DH. Undernutrition and risk of mortality in elderly patients within 1 year of hospital discharge. J Gerontol Med Sci. 2002;57A:M741-M746.
30. Evans WJ. Exercise as the standard of care for elderly people. J Gerontol Med Sci. 2002;57A:M260-M261.
31. Singh MAF. Exercise comes of age: rationale and recommendations for a geriatric exercise prescription. J Gerontol Med Sci. 2002;57A:M262-M282.
32. Trappe S, Wiliamson D, Godard M. Maintenance of whole muscle strength and size following resistance training in older men. J Gerontol Biol Sci. 2002;57A:B138-B143.
33. King AC. Interventions to promote physical activity by older adults. J Gerontol Med Sci. 2001;56(special issue 2):36-46.
34. Stewart AL, Verboncoeur CJ, McLellan BY, et al. Physical activity outcomes of CHAMPS II: a physical activity promotion program for older adults. J Gerontol Med Sci. 2001;56A:M465-M470.
35. Keysor JJ, Jette AM. Have we oversold the benefit of late-life exercise? J Gerontol Med Sci. 2001;56A:M412-M423.
36. Ploutz-Snyder LL, Giamis EL, Formikell M, Rosenbaum AE. Resistance training reduces susceptibility to eccentric exercise-induced muscle dysfunction in older women. J Gerontol Biol Sci. 2001;56A:B384-B390.
37. Nourhashemi F, Andrieu S, Gillette-Guyonnet S, Vellas B, Albarede JL, Grandjean H. Instrumental activites of daily living as a potential marker of frailty: a study of 7364 community-dwelling elderly women (the EPIDOS Study). J Gerontol Med Sci. 2001;56A:M448-M453.
38. Walter LC, Brand RJ, Counsell SR, et al. Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization. JAMA. 2001;285:2987-2994.
39. Fried TR, Bradley EH, Williams CS, Tinetti ME. Functional disability and health care expenditures for older persons. Arch Intern Med. 2001;161:2602-2607.
40. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol Med Sci. 2001;56A:M146-M156.
41. Walston J, Fried LP. Frailty and the older man. Med Clin North Am. 1999;83:1173.
42. Newman AB, Gottdiener JS, McBurnie MA, et al. Associations of subclinical cardiovascular disease with frailty. J Gerontol Med Sci. 2001;56A:M158-M166.
43. Lipsitz LA. Dynamics of stability: the physiologic basis of functional health and frailty. J Gerontol Biol Sci. 2002;57A:B1156-B125.
44. Gillick M. Pinning down frailty. J Gerontol Med Sci. 2001;56A:M134-M135.
45. Bortz WM. A conceptual framework of frailty: a review. J Gerontol Med Sci. 2002;57A:M283-M288.
46. Morley JE, Perry HM III, Miller DK. Something about frailty. J Gerontol Med Sci. 2002;57A:M698-M704.
47. Yashin AI, Ukraintseva SV, de Benedictis G, et al. Have the oldest old adults ever been frail in the past? A hypothesis that explains modern trends in survival. J Gerontol Biol Sci. 2001;56A:B432-B442.
48. Landers KA, Hunter GR, Wetzstein CJ, Bamman MM, Weinsier RL. The interrelationship among muscle mass, strength, and the ability to perform physical tasks of daily living in younger and older women. J Gerontol Biol Sci. 2001;56A:B443-B448.
49. Raji MA, Ostir GV, Markides KS, Goodwin JS. The interaction of cognitive and emotional status on subsequent physical functioning in older Mexican Americans: findings from the Hispanic established population for the epidemiologic study of the elderly. J Gerontol Med Sci. 2002;57A:M678-M682.
50. Morley JE. A fall is a major event in the life of an older person. J Gerontol Med Sci. 2002;57A:M492-M495.
51. Lan TY, Melzer D, Tom BDM, Guralnik JM. Performance tests and disability: developing an objective index of mobility-related limitation in older populations. J Gerontol Med Sci. 2002;57A:M294-M301.
52. Lord SR, Fitzpatrick RC. Choice stepping reaction time: a composite measure of falls risk in older people. J Gerontol Med Sci. 2001;56A:M627-M632.
53. Onder G, Penninx BWJH, Lapuerta P, et al. Change in physical performance over time in older women: the Women's Health and Aging Study. J Gerontol Med Sci. 2002;57A:M289-M293.
54. Jylha M, Guralnik JM, Balfour J, Fried LP. Walking difficulty, walking speed, and age as predictors of self-rated health: the Women's Health and Aging Study. J Gerontol Med Sci. 2001;56A:M609-M617.
55. Kwon IS, Oldaker S, Schrager M, Talbot LA, Fozard JL, Metter EJ. Relationship between muscle strength and the time taken to complete a standardized walk-turn-walk test. J Gerontol Biol Sci. 2001;56A:B398-B404.
56. Markides KS, Black SA, Ostir GV, Angel RJ, Guralnik JM, Lichtenstein M. Lower body function and mortality in Mexican American elderly people. J Gerontol Med Sci. 2001;56A:M243-M247.
57. McGuigan MRM, Bronks R, Newton RU, et al. Resistance training in patients with peripheral arterial disease: effects on myosin isoforms, fiber type distrubtion, and capillary supply to skeletal muscle. J Gerontol Biol Sci. 2001;56A:B302-B310.
58. Gardner AW, Montgomery PS. Impaired balance and higher prevalence of falls in subjects with intermittent claudication. J Gerontol Med Sci. 2001;56A:M454-M458.
59. Visser M, Pahor M, Taaffe DR, et al. Relationship of inteleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women. The Health ABC Study. J Gerontol Med Sci. 2002;57A:M326-M332.
60. Yeh SS, Wu SY, Levine DM, et al. The correlation of cytokine levels with body weight after megestrol acetate treatment in geriatric patients. J Gerontol Med Sci. 2001;56A:M48-M54.
61. Ceccarelli E, Donati C, Forconi S, Masotti L. C-reactive protein, physical disability, and prognosis in very old patients with ischemic stroke. J Gerontol Med Sci. 2002;57A:M520-M522.
62. Morley JE. Anorexia, sarcopenia, and aging. Nutrition. 2001;17:660-663.
63. Zamboni M, Zoico E, Tosoni P, et al. Relation between vitamin D, physical performance, and disability in elderly persons. J Gerontol Med Sci. 2002;57A:M7-M11.
64. Morley JE. Andropause: is it time for the geriatrician to treat it? J Gerontol Med Sci. 2001;56A:M263-M265.
65. Kenny AM, Prestwood KM, Gruman CA, Marcello KM, Raisz LG. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol Med Sci. 2001;56A:M266-M272.
66. Matsumoto AM. Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol Med Sci. 2002;57A:M76-M99.
67. Christmas C, O'Connor KG, Harman SM, et al. Growth hormone and sex steroid effects on bone metabolism and bone mineral density in healthy aged women and men. J Gerontol Med Sci. 2002;57A: M12-M18.
68. Morley JE. Androgens and aging. Maturitas. 2001;38:61-71.
69. Sucich IM, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol Med Sci. 2002;57A:M772-M777.
70. Rich MW. Heart failure in the 21st century: a cardiogeriatric syndrome. J Gerontol Med Sci. 2001;56A:M88-M96.
71. Aronow WS, Ahn C, Gutstein H. Prevalence and incidence of cardiovascular disease in 1160 older men and 2464 women in a long-term health care facility. J Gerontol Med Sci. 2002;57A:M45-M46.
72. Rigaud AS, Forette B. Hypertension in older adults. J Gerontol Med Sci. 2001;56A:M217-M225.
73. Aronow WS. What is the appropriate treatment of hypertension in elders? J Gerontol Med Sci. 2002;57A:M483-M486.
74. Hajjar I, Miller K, Hirth V. Age-related bias in the management of hypertension: a national survey of physicians' opinions on hypertension in elderly adults. J Gerontol Med Sci. 2002;57A:M487-M491.
75. Mya MM, Aronow WS. Subclinical hypothyroidism is associated with coronary artery disease in older persons. J Gerontol Med Sci. 2002;57A:M658-M659.
76. Lindmark E, Diderholm E, Wallentin L, Siegbahn A. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. JAMA. 2001;286:2107-2113.
77. Albert CM, Campos H, Stampfer MJ, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002;346:1113-1138.
78. Daviglus ML, Stamler J, Orencia AJ, et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med. 1997;336:1046-1053.
79. Aronow WS. Treatment of older persons with hypercholesterolemia with and without cardiovascular disease. J Gerontol Med Sci. 2001; 56A:M138-M145.
80. Aronow WS. Should hypercholesterolemia in older persons be treated to reduce cardiovascular events? J Gerontol Med Sci. 2002;57A:M411-M413.
81. Ghosh S, Ziesmer V, Aronow WS. Underutilization of aspirin, beta blockers, angiotensin-converting enzyme inhibitors, and lipid-lowering drugs and overutilization of calcium channel blockers in older persons with coronary artery disease in an academic nursing home. J Gerontol Med Sci. 2002;57A:M398-M400.
82. Benner JS, Glynn Rj, Mogun H, et al. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288:455-461.
83. Schatz IJ, Masaki K, Yano K, Chen R, Rodriguez BL, Curb JD. Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet. 2001;358: 351-355.
84. Sullivan DH. What do the serum proteins tell us about our elderly patients? J Gerontol Med Sci. 2001;56A:M71-M74.
85. Thomas DR, Ashmen W, Morley JE, Evans WJ. Nutritional management in long-term care: development of a clinical guideline. J Gerontol Med Sci. 2000;55A:M723-M734.
86. Omran ML, Morley JE. Assessment of protein energy malnutrition in older persons, part II: laboratory evaluation. Nutrition. 2000;16:131-140.
87. Aronow WS. Management of the older person with atrial fibrillation. J Gerontol Med Sci. 2002;57A:M352-M363.
88. White RH, Gettner S, Newman JM, Trauner KB, Romano PS. Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty. N Engl J Med. 2000;343:1758-1764.
89. McCormick D, Gurwitz JH, Goldberg RJ, et al. Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting. Arch Intern Med. 2001;161:2458-2463.
90. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med. 2001;345:1230-1236.
91. The TIME Investigators. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomized trial. Lancet. 2001;358:951-957.
92. Alamowitch S, Eliasziw M, Algra A, et al. Risk, causes, and prevention of ischaemic stroke in elderly patients with symptomatic internal-carotid-artery stenosis. Lancet. 2001;357:1154-1160.
93. Soumerai SB, McLaughlin TJ, Ross-Degnan D, Christiansen CL, Gurwitz JH. Effectiveness of thrombolytic therapy for acute myocardial infarction in the elderly: cause of concern in the old-old. Arch Intern Med. 2002;162:561-568.
94. Morley JE, Farr SA, Flood JF. Antibody to amyloid beta protein alleviates impaired acquisition, retention, and memory processing in SAMP8 mice. Neurobiol Learn Mem. 2002;78:125-138.
95. Kienlan-Campard P, Octave JN. Correlation between beta-amyloid peptide production and human APP-induced neuronal death. Peptides. 2002;23:1199-1204.
96. Evin G, Weidemann A. Biogenesis and metabolism of Alzheimer's disease A beta amyloid peptides. Peptides. 2002;23:1283-1297.
97. Rottkamp CA, Atwood CS, Joseph JA, Nunomura A, Perry G, Smith MA. The state versus amyloid-beta: the trial of the most wanted criminal in Alzheimer disease. Peptides. 2002;23:1333-1341.
98. Neuropathology Group, Medical Research Council Cognitive Function and Aging Study. Pathological correlates of late-onset dementia in a nmlticentre, community-based population in England and Wales. Lancet. 2001;357:169-175.
99. Andreasen N, Blennow K. Beta-amyloid (A beta) protein in cerebrospinal fluid as a biomarker for Alzheimer's disease. Peptides. 2002;23:1204-1214.
100. Flood JF, Roberts E, Sherman MA, Kaplan BE, Morley JE. Topography of a binding site for small amnestic peptides deduced from structure activity studies - relation to amnestic effect of amyloid beta-protein. Proc Natl Acad Sci USA. 1994;91:380-384.
101. Chen GQ, Chen KS, Knox J, et al. A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature. 2000;408:975-979.
102. Helmuth L. Alzheimer's Congress - further progress on beta-amyloid vaccine. Science. 2000;289:375.
103. Hsiao K, Chapman P, Nilsen S, et al. Correlative memory deficits, A-beta elevation, and amyloid plaques in transgenic mice. Science. 1996;274:99-102.
104. Janus C, Pearson J, McLaurin J, et al. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature. 2000;408(6815):979-982.
105. Morley JE, Farr SA, Kumar VB, Banks WA. Alzheimer's disease through the eye of a mouse - acceptance lecture for the 2001 Gayle A. Olson and Richard D. Olson prize. Peptides. 2002;23:589-599.
106. Morley JE, Farr SA, Flood JF. Antibody to amyloid beta protein alleviates impaired acquisition, retention, and memory processing in SAMP8 mice. Neurobiol Learn Mem. 2002;48:125-138.
107. Morley JE, Kumar VB, Bernardo AE, et al. Beta-amyloid precursor polypeptide in SAMP8 mice affects learning and memory. Peptides. 2000;21:1761-1767.
108. Kumar VB, Farr SA, Flood JF, et al. Site-directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice. Peptides. 2000;21:1769-1775.
109. Tran MH, Yamada K, Nabeshima T. Amyloid beta-peptide induces cholinergic dysfunction and cognitive deficits: a minireview. Peptides. 2002;23:1271-1283.
110. Banks WA, Farr SA, Butt W, Kumar VB, Franko MW, Morley JE. Delivery across the blood-brain barrier of antisense directed against amyloid beta: reversal of learning and memory deficits in mice overexpressing amyloid precursor protein. J Pharmacol Exp. Therap. 2001;297:1113-1121.
111. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 2002; 346:476-483.
112. Bookheimer SY, Strojwas MH, Cohen MS, et al. Patterns of brain activation in people at risk for Alzheimer's disease, N Engl J Med. 2000;343:450-456.
113. Reynish W, Andrieu S, Nourhashemi F, Vellas B. Nutritional factors and Alzheimer's disease. J Gerontol Med Sci. 2001;56A:M675-M680.
114. Hajjar L, Schumpert J, Hirth V, Wieland D, Eleazer GP. The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment. J Gerontol Med Sci. 2002;57A:M414-M418.
115. Simmons SF, Osterweil D, Schnelle JF. Improving food intake in nursing home residents with feeding assistance: a staffing analysis. J Gerontol Med Sci. 2001;56A:M79-M794.
116. Young KWH, Greenwood CE. Shift in diurnal feeding patterns in nursing home residents with Alzheimer's disease. J Gerontol Med Sci. 2001;56A:M700-M706.
117. Young KWH, Binns MA, Greenwood CE, Meal delivery practices do not meet needs of Alzheimer patients with increased cognitive and behavioral difficulties in a long-term care facility. J Gerontol Med Sci. 2001;56A:M656-M661.
118. de Castro JM. Age-related changes in the social, psychological, and temporal influences on food intake in free-living, healthy, adult humans. J Gerontol Med Sci. 2002;57A:M368-M377.
119. Suda Y, Marske CE, Flaherty JH, Zdrodowski K, Morley JE. Examining the effect of intervention to nutritional problems of the elderly living in an inner city area: a pilot project. J Nutr Hlth Aging. 2001;5:118-123.
120. Tabbarah M, Crimmins EM, Seeman TE. The relationship between cognitive and physical performance: MacArthur Studies of Successful Aging. J Gerontol Med Sci. 2002;57A:M228-M235.
121. Guo XX, Steen B, Matousek M, et al. A population-based study on brain atrophy and motor performance in elderly women. J Gerontol Med Sci. 2001;56A:M633-M637.
122. Blaum CS, Ofstedal MB, Liang J. Low cognitive performance, comorbid disease, and task-specific disability: findings from a nationally representative survey. J Gerontol Med Sci. 2002;57A:M523-M531.
123. Sands LP, Yaffe K, Lui LY, Stewart A, Eng C, Covinsky K. The effects of acute illness on ADL decline over I year in frail older adults with and without cognitive impairment. J Gerontol Med Sci. 2002; 57A:M449-M454.
124. Fletcher PC, Hirdes JP. Risk factors for falling among community-based seniors using home care services. J Gerontol Med Sci. 2002; 57A:M504-M510.
125. Robison J, Gruman C, Gaztambide S, Blank K. Screening for depression in middle-aged and older Puerto Rican primary care patients. J Gerontol Med Sci. 2002;57A:M308-M314.
126. Kenny AM, Bellantionio S, Gruman CA, Acosta RD, Prestwood KM. Effects of transdermal testosterone on cognitive function and health perception in older men with low bioavailable testosterone levels. J Gerontol Med Sci. 2002;57A:M321-M325.
127. Petitti DB, Buckwalter G, Crooks VC, Chiu V. Prevalence of dementia in users of hormone replacement therapy as defined by prescription data. J Gerontol Med Sci. 2002;57A:M532-M538.
128. van Asselt DZ, Pasman JW, van Lier JH, et al. Cobalamin supplementation improves cognitive and cerebral function in older, cobalamin-deficient persons. J Gerontol Med Sci. 2001;56A:M775-M779.
129. Hebert R, Dubois MF, Wolfson C, Chambers L, Cohen C. Factors associated with long-term institutionalization of older people with dementia: data from the Canadian Study of Health and Aging. J Gerontol Med Sci. 2001;56A:M693-M699.
130. Brauer SG, Woollacott M, Shumway-Cook A. The interacting effects of cognitive demand and recovery of postural stability in balance-impaired elderly persons. J Gerontol Med Sci. 2001;56A:M489-M496.
131. Bula CJ, Wietlisbach V, Burnand B, Yersin B. Depressive symptoms as a predictor of 6-month outcomes and services utilization in elderly medical inpatients. Arch Int Med. 2001;161:2609-2615.
132. Blazer DG, Hybels CF, Pieper CF. The association of depression and mortality in elderly persons: a case for multiple, independent pathways. J Gerontol Med Sci. 2001;56A:M505-M509.
133. Doraiswamy PM, Khan ZM, Donahue RMJ, Richard NE. The spectrum of quality-of-life impairments in recurrent geriatric depression. J Gerontol Med Sci. 2001;57A:M134-M137.
134. Singh NA, Clements KM, Singh MAF. The efficacy of exercise as a long-term antidepressant in elderly subjects: a randomized, controlled trial. J Gerontol Med Sci. 2001;56A:M497-M504.
135. Sumaya IC, Rienzi BM, Deegan JF, Moss DE. Bright light treatment decreases depression in institutionalized older adults: a placebo-controlled crossover study. J Gerontol Med Sci. 2001;56A:M356-M360.
136. Ben-Noun LL. What was the disease of the bones that affected King David? J Gerontol Med Sci. 2002;57A:M152-M154.
137. Hannan EL, Magaziner J, Wang JJ, et al. Mortality and locomotion 6 months after hospitalization for hip fractures: risk factors and risk-adjusted hospital outcomes. JAMA. 2001;285:2736-2742.
138. Zimmerman S, Chandler JM, Hawkes W, et al. Effect of fracture on the health care use of nursing home residents. Arch Intern Med. 2002;162:1502-1508.
139. Perry HM 3rd. Facets of femoral fracture. J Gerontol Med Sci. 2000; 55A:M487-M488.
140. Magaziner J, Hawkes W, Hebel JR, et al. Recovery from hip fracture in eight areas of function. J Gerontol Med Sci. 2000;55A:M498-M507.
141. Michel JP, Hoffmeyer P, Klopfenstein C, Bruchez M, Grab B, d'Epinay CL. Prognosis of functional recovery 1 year after hip fracture: typical patient profiles through cluster analysis. J Gerontol Med Sci. 2000;55A:M508-M515.
142. Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA. 2001;286:2815-2822.
143. Khan SA, de Geus C, Holroyd B, Russell AS. Osteoporosis follow-up after wrist fractures following minor trauma. Arch Intern Med. 2001;161:1309-1312.
144. Kamel HK, Hussain MS, Tariq S, Perry HM, Morley JE. Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture. Am J Med. 2000;109:326-328.
145. Reid IR, Brown JP, Burckhardt P, et al. Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med. 2002;346:653-661.
146. Orwoll E, Ettinger M, Weiss S, et al. Alendronate for the treatment of osteoporosis in men. N Engl J Med. 2000;343:604-610.
147. Kannus P, Parkkari J, Niemi S, et al. Prevention of hip fracture in elderly people with use of a hip protector. N Engl J Med. 2000;343:1506-1513.
148. Pitkala KH, Strandberg TE, Tilvis RS. Inappropriate drug prescribing in home-dwelling, elderly patients: a population-based survey. Arch Intern Med. 2002;162:1707-1712.
149. Agostini JV, Leo-Summers LS, Inouye SK. Cognitive and other adverse effects of diphenhydramine use in hospitalized older patients. Arch Intern Med. 2001;161:2091-2097.
150. Field TS, Gurwitz JH, Avorn J, et al. Risk factors for adverse drug events among nursing home residents. Arch Intern Med. 2001;161:1629-1634.
151. Flaherty JH, Perry HM 3rd, Lynchard GS, Morley JE. Polypharmacy and hospitalization among older home care patients. J Gerontol Med Sci. 2000;55A:M554-M559.
152. Edelberg HK, Shallenberger E, Hausdorff JM, Wei JY. One-year follow-up of medication management capacity in highly functioning older adults. J Gerontol Med Sci. 2000;55A:M550-M553.
153. Cohen RJ, Ek K, Pan CX. Complementary and alternative medicine (CAM) use by older adults: a comparison of self-report and physician chart documentation. J Gerontol Med Sci. 2002;57A:M223-M227.
154. Loera JA, Black SA, Markides KS, Espino DV, Goodwin JS. The use of herbal medicine by older Mexican Americans. J Gerontol Med Sci. 2001;56A:M714-M718.
155. Flaherty JH, Takahashi R, Teoh J, et al. Use of alternative therapies in older outpatients in the United States and Japan: prevalence, reporting patterns, and perceived effectiveness. J Gerontol Med Sci. 2001;56A:M650-M655.
156. Morley JE. Drugs, aging, and the future. J Gerontol Med Sci. 2002; 57A:M2-M6.
157. Flaherty JH. Who's taking your 5th vital sign? J Gerontol Med Sci. 2001;56A:M397-M399.
158. Kamel HK, Phlavan M, Malekgoudarzi B, Gogel P, Morley JE. Utilizing pain assessment scales increases the frequency of diagnosing pain among elderly nursing home residents. J Pain Sympt Mgt. 2001; 21:450-455.
159. Al Snih A, Markides KS, Ray L, Goodwin JS. Impact on pain on disability among older Mexican Americans. J Gerontol Med Sci. 2001;56A:M400-M404.
160. Reid MC, Guo Z, Towle VR, Kerns RD, Concato J. Pain-related disability among older male veterans receiving primary care. J Gerontol Med Sci. 2002;57A:M727-M732.
161. Baldwin AC, Stevenson SW, Dudley GA. Nonsteroidal anti-inflammatory therapy after ecdentric exercise in healthy older individuals. J Gerontol Med Sci. 2001;56A:M510-M513.
162. Lisse J, Espinoza L, Zhao SZ, Dedhiya SD, Osterhaus JT. Functional status and health-related quality of life of elderly osteoarthritic patients treated with celecoxib. J Gerontol Med Sci. 2001;56A:M167-M175.
163. Thomas DR. Issues and dilemmas in the prevention and treatment of pressure ulcers: a review. J Gerontol Med Sci. 2001;56A:M328-M340.
164. Lyder CH, Preston J, Grady JN, et al. Quality of care for hospitalized medicare patients at risk for pressure ulcers. Arch Intern Med. 2001;161:1549-1554.
165. Stotts NA, Rodeheaver GT, Thomas DR, et al. An instrument to measure healing in pressure ulcers: development and validation of the pressure ulcer scale for healing (PUSH). J Gerontol Med Sci. 2001; 56A:M795-M799.
166. Mehr DR, Binder EF, Kruse RL, et al. Predicting mortality in nursing home residents with lower respiratory tract infection: The Missouri LRI Study. JAMA. 2001;50:931-937.
167. McElhaney JE. Nutrition, exercise and influenza vaccination. J Gerontol Med Sci. 2002;57A:M555-M557.
168. Wouters-Wesseling W, Rozendaal M, Snyder M, et al. Effect of a complete nutritional supplement on antibody response to influenza vaccine in elderly. J Gerontol Med Sci. 2002;57A:M563-M566.
169. Rotstein R, Zeltser D, Shapira I, et al. The usefulness of an inflammation meter to detect the presence of infection/inflammation in elderly patients. J Gerontol Med Sci. 2002;57A:M122-M127.
170. Warshaw G, Mehdizadeh S, Applebaum RA. Infections in nursing homes: assessing quality of care. J Gerontol Med Sci. 2001;56A:M120-M123.
171. McElhaney JE. Influenza: a preventable lethal disease. J Gerontol Med Sci. 2002;57A(10):M627-M628.
172. Morley JE, Flaherty JH. It's never too late: health promotion and disease prevention in older persons. J Gerontol Med Sci. 2002;57A:M338-M342.
173. Deguchi Y, Nishimura K. Efficacy of influenza vaccine in elderly persons in welfare nursing homes: reduction in risks of mortality and morbidity during an influenza A (H3N2) epidemic. J Gerontol Med Sci. 2001;56A:M391-M394.
174. Menec VH, MacWilliam L, Aoki FY. Hospitalizations and deaths due to respiratory illnesses during influenza seasons: a comparison of community residents, senior housing residents, and nursing home residents. J Gerontol Med Sci. 2002;57A:M629-M635.
175. Salerno JA, Nagy C. Terrorism and aging [Editorial]. J Gerontol Med Sci. 2002;57A:M552-M554.
176. Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med. 2001;344:1807-1814.
177. Wilson MM, Philpott CD, Breer WA. Atypical presentation of scabies among nursing home residents. J Gerontol Med Sci. 2001;56A:M424-M427.
178. Hinton S, Sandler A. Lung cancer in the elderly - current and future chemotherapeutic options. Drugs Aging. 2002;19:365-375.
179. Wolinsky FD, Krygiel J, Wyrwich KW. Hospitalization for prostate cancer among the older men in the Longitudinal Study on Aging, 1984-1991. J Gerontol Med Sci. 2002;57A:M115-M121.
180. Solignac M. Life expectancy and aging, scientific and medical aspects [French]. Presse Medicale. 2002;31(17):781-786.
181. Murphy DJ, Gahm GJ, Santilli S, North P, Oliver SCN, Shapiro H. Seniors' preferences for cancer screening and medication use based on absolute risk reduction. J Gerontol Med Sci. 2002;57A:M100-M105.
182. Flaherty JH, Morley JE, Murphy DJ, Wasserman MR. The development of outpatient clinical Glidepaths. J Am Geriatr Soc. In press.
183. Michel J-P, Pautex S, Zekry D, Zulian G, Gold G. End-of-life care of persons with dementia. J Gerontol Med Sci. 2002;57A:M640-M644.
184. Schwartz CE, Wheeler HB, Hammes B, et al. Early intervention planning end-of-life care with ambulatory geriatric patients: results of a pilot trial. Arch Intern Med. 2001;162:1611-1618.
185. Back AL, Starks H, Hsu C, et al. Clinician-patient interactions about requests of physician-assisted suicide: a patient and family view. Arch Intern Med. 2002;162:1257-1265.
186. von Faber M, Bootsma-van der Wiel A, van Exel E, et al. Successful aging in the oldest old: who can be characterized as successfully aged? Arch Intern Med. 2001;161:2694-2700.
187. Uhlmann RF, Pearlman RA. Perceived quality of life and preferences for life-sustaining treatment in older adults. Arch Intern Med. 1991;151:495-497.
188. Kane RL. The future history of geriatrics: geriatrics at the crossroads. J Gerontol Med Sci. 2002;57A:M803-M805.
189. Hazzard WR. Geriatrics at the crossroads - or simply early in the journey? J Gerontol Med Sci. 2002;57A:M806.
190. Warshaw G. Commentary [Kane RL. The future history of geriatrics]. J Gerontol Med Sci. 2002;57A:M806-M807.
191. Rodin MB. Commentary [Kane RL. The future history of geriatrics]. J Gerontol Med Sci. 2002;57A:M807-M808.
192. Flaherty JH. The adolescence of geriatrics. J Gerontol Med Sci. 2002; 57A:M808-M811.
193. Tangalos EG. Commentary [Kane RL. The future history of geriatrics]. J Gerontol Med Sci. 2002;57A:M811.
194. Sinclair AJ. Commentary [Kane RL. The future history of geriatrics]. J Gerontol Med Sci. 2002;57A:M811-M812.
195. Michel J-P. Commentary [Kane RL. The future history of geriatrics]. J Gerontol Med Sci. 2002;57A:M812-M813.
196. Singh MF. Letter to the Editor: Commentary on Dr. Kane's article. The future history of geriatrics: geriatrics at the crossroads. J Gerontol Med Sci. 2003;58A:92-93.
197. Thomas DR. Letter to the Editor: The future history of geriatrics: consulting the experts. J Gerontol Med Sci. 2003;58A:92.
198. Miller DK, Carter ME, Miller JP, et al. Inner-city older blacks have high levels of functional disability. J Am Geriatr Soc. 1996;44:1166-1173.
199. Miller DK, Coe RM, Romeis JC, Morley JE. Improving quality of geriatric health care in four delivery sites: suggestions from practitioners and experts. J Am Geriatr Soc. 1995;43:60-65.
200. Morley JE, Miller DK. Total quality assurance: an important step in improving care for older individuals. J Am Geriatr Soc. 1992;40:974-975.
201. Simmons SF, Babineau S, Garcia E, Schnelle JF. Quality assessment in nursing homes by systematic direct observations: feeding assistance. J Gerontol Med Sci. 2002;57A:M665-M671.
202. Thomas DR. Focus on functional decline in hospitalized older adults. J Gerontol Med Sci. 2002;57A:M567-M568.
203. McCusker J, Kakuma R, Abrahamowicz M. Predictors of functional decline in hospitalized elderly patients: a systematic review. J Gerontol Med Sci. 2002;57A:M569-M577.
204. Cohen HJ, Feussner JR, Weinberger M, et al. A controlled trial of inpatient and outpatient geriatric evaluation and management. N Engl J Med. 2002;346;905-912.
205. Inoue SK, Bogardus ST, Charpentier PA, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med. 1999;340:669-676.
206. Flaherty JH, Tariq S, Raghavan S, Bakshi S, Moinnudin A, Morley JE. The delirium room: a new type of intensive care unit. J Am Geriatr Soc. In press.
207. Hubert HB, Bloch DA, Oehlert JW, Fries JF. Lifestyle habits and compression of morbidity. J Gerontol Med Sci. 2002;57A:M347-M351.